Schottelius M - Search Results

1

N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo.

Schottelius M, Reubi JC, Eltschinger V, Schwaiger M, Wester HJ. Schottelius M, et al. J Med Chem. 2005 Apr 21;48(8):2778-89. doi: 10.1021/jm040794i. J Med Chem. 2005. PMID: 15828816

2

Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics.

Wester HJ, Schottelius M, Scheidhauer K, Reubi JC, Wolf I, Schwaiger M. Wester HJ, et al. Among authors: schottelius m. Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):28-38. doi: 10.1007/s00259-001-0669-1. Epub 2001 Nov 1. Eur J Nucl Med Mol Imaging. 2002. PMID: 11807604

3

Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates.

Schottelius M, Wester HJ, Reubi JC, Senekowitsch-Schmidtke R, Schwaiger M. Schottelius M, et al. Bioconjug Chem. 2002 Sep-Oct;13(5):1021-30. doi: 10.1021/bc0200069. Bioconjug Chem. 2002. PMID: 12236784

4

PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.

Wester HJ, Schottelius M, Scheidhauer K, Meisetschläger G, Herz M, Rau FC, Reubi JC, Schwaiger M. Wester HJ, et al. Among authors: schottelius m. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):117-22. doi: 10.1007/s00259-002-1012-1. Epub 2002 Nov 5. Eur J Nucl Med Mol Imaging. 2003. PMID: 12483418

5

Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.

Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, Kessler H, Schwaiger M, Wester HJ. Poethko T, et al. Among authors: schottelius m. J Nucl Med. 2004 May;45(5):892-902. J Nucl Med. 2004. PMID: 15136641

6

First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.

Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, Wester HJ. Schottelius M, et al. Clin Cancer Res. 2004 Jun 1;10(11):3593-606. doi: 10.1158/1078-0432.CCR-03-0359. Clin Cancer Res. 2004. PMID: 15173065

7

Radiolabeled carbohydrated somatostatin analogs: a review of the current status.

Wester HJ, Schottelius M, Poethko T, Bruus-Jensen K, Schwaiger M. Wester HJ, et al. Among authors: schottelius m. Cancer Biother Radiopharm. 2004 Apr;19(2):231-44. doi: 10.1089/108497804323072011. Cancer Biother Radiopharm. 2004. PMID: 15186604 Review.

8

Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET.

Henriksen G, Schottelius M, Poethko T, Hauser A, Wolf I, Schwaiger M, Wester HJ. Henriksen G, et al. Among authors: schottelius m. Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1653-7. doi: 10.1007/s00259-004-1582-1. Epub 2004 Aug 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 15309330

9

Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.

Schottelius M, Rau F, Reubi JC, Schwaiger M, Wester HJ. Schottelius M, et al. Bioconjug Chem. 2005 Mar-Apr;16(2):429-37. doi: 10.1021/bc0499228. Bioconjug Chem. 2005. PMID: 15769098

10

[123I]Mtr-TOCA, a radioiodinated and carbohydrated analogue of octreotide: scintigraphic comparison with [111In]octreotide.

Stahl A, Meisetschläger G, Schottelius M, Bruus-Jensen K, Wolf I, Scheidhauer K, Schwaiger M. Stahl A, et al. Among authors: schottelius m. Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):45-52. doi: 10.1007/s00259-005-1872-2. Epub 2005 Sep 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16151771 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results